20 July 2026
: Case report
[In Press] Delayed Diagnosis of Type 1 Gaucher Disease at Age 15 After Years of Mild Cytopenias and Splenomegaly: A Case Report and Long-Term Follow-Up
Challenging differential diagnosis, Diagnostic / therapeutic accidents, Rare disease
Katarzyna Muras-SzwedziakDOI: 10.12659/AJCR.952793
Am J Case Rep In Press; DOI: 10.12659/AJCR.952793
Available online: 2026-07-20, In Press, Corrected Proof
Publication in the "In-Press" formula aims at speeding up the public availability of the pending manuscript while waiting for the final publication. The assigned DOI number is active and citable. The availability of the article in the Medline, PubMed and PMC databases as well as Web of Science will be obtained after the final publication according to the journal schedule
Abstract
BACKGROUND
Gaucher disease (GD) is the most common lysosomal storage disorder caused by glucocerebrosidase deficiency. Type 1 GD (GD1) often presents with nonspecific manifestations, including splenomegaly, cytopenias, growth impairment, and skeletal involvement, leading to delayed diagnosis and irreversible complications. This report highlights the delayed diagnosis of GD1 in a patient with longstanding mild manifestations and emphasizes the importance of considering GD in patients with unexplained cytopenias and splenomegaly.
CASE REPORT
We describe a male patient with GD1 whose first manifestations appeared in infancy and included splenomegaly. During childhood, persistent cytopenias, hepatosplenomegaly, and growth deceleration were observed; however, the diagnosis remained unrecognized. At age 14, the patient developed severe skeletal pain accompanied by fever, prompting further diagnostic evaluation. Imaging studies revealed bone marrow abnormalities, and bone biopsy demonstrated foamy macrophages but did not establish a definitive diagnosis. At age 15, GD1 was suspected and subsequently confirmed by enzymatic testing, biomarker assessment, and genetic analysis. Enzyme replacement therapy with imiglucerase resulted in clinical improvement, reduced organomegaly, and stabilization of laboratory parameters. The patient subsequently underwent a structured transition from pediatric to adult care without treatment interruption.
CONCLUSIONS
GD should be considered in patients with unexplained splenomegaly and persistent cytopenias, even when early manifestations are mild and nonspecific. Early recognition and disease-specific diagnostic testing may reduce diagnostic delay, facilitate timely treatment initiation, and help prevent irreversible complications. This case also highlights the importance of a structured transition from pediatric to adult care in maintaining long-term treatment continuity.
Keywords: Delayed Diagnosis; Enzyme Replacement Therapy; Gaucher Disease; Lysosomal Storage Diseases; Transitional Care; Case Reports
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.952791
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.952909
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950868
Most Viewed Current Articles
07 Dec 2021 : Case report
22,759,007
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
175,837
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
120,449
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
65,460
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






